In this study, we first evaluated associations between 2,060 genetic variants of 20 genes in the NF-κB signaling pathway and HBV-HCC survival of 866 patients using a discovery dataset and validation dataset. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.